BRAF and prostate carcinoma: These BRAF rearrangement events were also seen with some frequency at the prostate cancer level, as our group recently examined 15,864 prostate tissue biopsies and 7,566 liquid biopsies, where we showed that 46.7% of prostate cancer patients harboring BRAF alterations exhibited structural rearrangements [13].